Step by Stepa HemeOncBuddy patient portal

Talazoparib

Illustration: Talazoparib

Say it: tal-a-ZOE-pa-rib · Brand names: Talzenna

Talazoparib is a targeted therapy pill called a PARP inhibitor that stops cancer cells from repairing their damaged DNA.

What it is

Cells use proteins called PARP to fix damaged DNA. Cancer cells with certain gene changes already have trouble fixing DNA. When talazoparib blocks PARP, these cancer cells cannot repair themselves and die.

Often used for

How you get it

Talazoparib is a capsule you take by mouth at home, once a day, with or without food. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Talazoparib?
Talazoparib is a targeted therapy pill called a PARP inhibitor that stops cancer cells from repairing their damaged DNA. Brand names: Talzenna.
What is Talazoparib used for?
HER2 negative breast cancer with an inherited BRCA gene change that is advanced or has spread; prostate cancer with certain gene changes that has spread, given with enzalutamide.
How is Talazoparib given?
Talazoparib is a capsule you take by mouth at home, once a day, with or without food. Your schedule may be different.
What are the common side effects of Talazoparib?
Low red blood cells (anemia), which can make you tired or short of breath. Feeling tired or weak. Feeling sick to your stomach or throwing up. Low white blood cells or platelets, which raise your chance of infection or bleeding. Headache. Hair thinning. Not feeling hungry or losing weight. Diarrhea.
When should I call my care team while taking Talazoparib?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Unusual bruising or bleeding, feeling very weak or tired, or getting infections often; Blood in your urine or stool; Shortness of breath or feeling very weak.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.